1
|
Park SY, Church C, Alexander NA, Shinohara MM, Paulson KG, Lewis KD, Lee NS, Nghiem P. Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients. JAAD Case Rep 2021; 8:28-33. [PMID: 33490342 PMCID: PMC7806538 DOI: 10.1016/j.jdcr.2020.11.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Key Words
- AIDS
- CR, complete response
- HIV
- ICI, immune checkpoint inhibitors
- IHC, immunohistochemistry
- MCC
- MCC, Merkel cell carcinoma
- MCPyV, Merkel cell polyomavirus
- Merkel cell carcinoma
- PD-1, anti-programmed cell death-1
- PD-L1, anti-programmed death ligand-1
- PET, positron emission tomography
- RT, radiation treatment
- aMCC, advanced Merkel cell carcinoma
- anti-PD-(L)1 agent
- immunotherapy
Collapse
Affiliation(s)
- Song Y Park
- University of Washington, Seattle, Washington
| | | | | | | | | | - Karl D Lewis
- University of Colorado Cancer Center, Aurora, Colorado
| | - Nancy S Lee
- Kaiser Permanente, Hematology and Oncology, San Diego, California
| | - Paul Nghiem
- University of Washington, Seattle, Washington
| |
Collapse
|